Truscreen announced a capital raising on Wednesday to fund growth plans in Asia.
Tim Hunter Wed, 20 May 2015
Several early shareholders in healthcare company Truscreen [NZX: TRU] sold down their holdings within days of the company listing last November, trading records show.
Truscreen, a marketer of cancer screening technology acquired from defunct Australian company Polartechnics, announced a capital
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).